Thousands of genes influence most diseases
In a provocative new perspective piece, Stanford researchers say that disease genes are spread uniformly across the genome, not clustered in specific molecular pathways, as has been thought.
A core assumption in the study of disease-causing genes has been that they are clustered in molecular pathways directly connected to the disease. But work by a group of researchers at the Stanford University School of Medicine suggests otherwise.
The gene activity of cells is so broadly networked that virtually any gene can influence disease, the researchers found. As a result, most of the heritability of diseases is due not to a handful of core genes, but to tiny contributions from vast numbers of peripheral genes that function outside disease pathways.
Any given trait, it seems, is not controlled by a small set of genes. Instead, nearly every gene in the genome influences everything about us. The effects may be tiny, but they add up.
The work is described in a paper published June 15 in Cell. Jonathan Pritchard, PhD, professor of genetics and of biology, is the senior author. Graduate student Evan Boyle and postdoctoral scholar Yang Li, PhD, share lead authorship.
The researchers call their provocative new understanding of disease genes an “omnigenic model” to indicate that almost any gene can influence diseases and other complex traits. In any cell, there might be 50 to 100 core genes with direct effects on a given trait, as well as easily another 10,000 peripheral genes that are expressed in the same cell with indirect effects on that trait, said Pritchard, who is also a Howard Hughes Medical Institute investigator.
Each of the peripheral genes has a small effect on the trait. But because those thousands of genes outnumber the core genes by orders of magnitude, most of the genetic variation related to diseases and other traits comes from the thousands of peripheral genes. So, ironically, the genes whose impact on disease is most indirect and small end up being responsible for most of the inheritance patterns of the disease.
“This is a compelling paper that presents a plausible and fascinating model to explain a number of confusing observations from genomewide studies of disease,” said Joe Pickrell, PhD, an investigator at the New York Genome Center, who was not involved in the work.
From a polygenic to omnigenic model
Until recently, said Pritchard, he thought of genetically complex traits as conforming to a polygenic model, in which each gene has a direct effect on a trait, whether that trait is something like height or a disease, such as autism.
The Latest on: Disease genes
- RD Fund Launches Opus Genetics with $19M Seed Funding to Advance Gene Therapy Treatments for Blinding Conditionson September 22, 2021 at 4:35 am
The Retinal Degeneration Fund (RD Fund), the venture arm of the Foundation Fighting Blindness aimed at rapidly driving research toward preventions, treatments and cures for the entire spectrum of ...
- Discovery of genes opens the door to new treatments for obesityon September 21, 2021 at 10:39 pm
Promising news in the effort to develop drugs to treat obesity: University of Virginia scientists have identified 14 genes that can cause and three that can prevent weight gain.
- Revolutionary genetic research could change the lives of those with rare diseaseson September 21, 2021 at 7:43 am
A biotech nonprofit is on the cusp of a treatment that could change the lives of those living with fatal diseases.
- A genetic brain disease reversed after birthon September 19, 2021 at 5:00 pm
September 17th was Kleefstra Syndrome Awareness Day! Researchers at the RIKEN Cluster for Pioneering Research (CPR) in Japan report that Kleefstra syndrome, a genetic disorder that leads to ...
- British soldier walking barefoot from Maine to North Carolina to raise money for research into daughter’s rare genetic diseaseon September 19, 2021 at 1:04 pm
In an effort to raise funds and awareness for treatment research, Chris Brannigan, who lives in the U.K., began in late August a 1,200-mile “Barefoot March” down the East Coast. He started at The ...
- Larimar Therapeutics to Participate in SVB Leerink CybeRx Series: Neuromuscular, Rare Diseases & Genetic Medicines Eventon September 16, 2021 at 5:00 am
Larimar Therapeutics, Inc. (“Larimar”) (Nasdaq: LRMR), a clinical-stage biotechnology company focused on developing treatments for complex rare diseases, today announced that company management will ...
- How Hereditary Is Parkinson's Disease? Here's Why You Shouldn't Panic About Your Genetic Riskon September 14, 2021 at 8:49 am
Genetic markers for Parkinson’s disease can run in families, but it’s rare to inherit the disease. Here’s what to consider if a parent or relative has Parkinson’s.
- Disease genes help developing brainson September 10, 2021 at 3:12 pm
If the cerebral hemispheres of the forebrain fail to divide properly in an unborn child, this results in holoprosencephaly. A team has discovered candidate genes that can positively influence the ...
- New gene-delivering workhorse could make gene therapy safer, more effective for muscle diseaseson September 9, 2021 at 8:24 pm
Genetic muscle diseases lead to progressive muscle wasting and often early death, with few treatment options and no cure.
- A new gene-delivery vehicle could make gene therapy for muscle diseases safer and more effectiveon September 9, 2021 at 8:00 am
Genetic muscle diseases lead to progressive muscle wasting and often early death, with few treatment options and no cure. Some gene therapies that use a harmless virus to deliver a functioning copy of ...
via Google News and Bing News